Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 2

4(50.0%)

Phase 3

2(25.0%)

Phase 4

1(12.5%)

N/A

1(12.5%)

8Total

Phase 2(4)

Phase 3(2)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05199324Phase 4Recruiting

Early Oral Switch for Uncomplicated Gram-negative Bacteraemia

Role: collaborator

NCT07028827Phase 3Recruiting

Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)

Role: collaborator

NCT07344090Not ApplicableRecruiting

USING A DECISION-MAKING SYSTEM TO SUPPORT THE MANAGEMENT OF FEVER AND ACUTE PAIN IN CHILDREN

Role: collaborator

NCT06894940Phase 2Completed

Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

Role: collaborator

NCT04966234Phase 2Unknown

A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection

Role: collaborator

NCT01825512Phase 3Completed

Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Role: lead

NCT02790996Phase 2Terminated

Neonatal Vancomycin Trial

Role: collaborator

NCT01740713Phase 2Completed

Pharmacokinetic Study of Deferiprone in Paediatric Patients

Role: lead

All 8 trials loaded